US Stock MarketDetailed Quotes

ESLA Estrella Immunopharma

Watchlist
  • 1.151
  • -0.090-7.22%
Close Jul 9 16:00 ET
  • 1.130
  • -0.021-1.78%
Post 18:14 ET
41.85MMarket Cap-2876P/E (TTM)

Estrella Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
(Q3)Mar 29, 2022
(Q2)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-82.87%469.53K
-62.97%1.02M
-35.17%1.87M
1,528.78%2.74M
2,502.95%2.76M
2.89M
129.71%1.69M
1.07M
168.29K
105.89K
Selling and administrative expenses
277.66%444.53K
536.85%945.17K
394.92%1.39M
745.08%117.71K
358.08%148.41K
--280.26K
7.16%296.25K
--32.26K
---18.25K
--32.4K
-General and administrative expense
277.66%444.53K
536.85%945.17K
394.92%1.39M
745.08%117.71K
358.08%148.41K
--280.26K
7.16%296.25K
--32.26K
---18.25K
--32.4K
Research and development costs
-99.05%25K
-97.11%75.46K
-81.44%483.47K
1,306.35%2.62M
3,448.49%2.61M
--2.61M
203.81%1.39M
--1.04M
--186.54K
--73.49K
Operating profit
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-1,528.78%-2.74M
-2,502.95%-2.76M
-2.89M
-129.71%-1.69M
-1.07M
-168.29K
-105.89K
Net non-operating interest income expense
Other net income (expense)
Income before tax
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-1,528.78%-2.74M
-2,502.95%-2.76M
-2.89M
-129.71%-1.69M
-1.07M
-168.29K
-105.89K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-1,528.78%-2.74M
-2,502.95%-2.76M
-2.89M
-129.71%-1.69M
-1.07M
-168.29K
-105.89K
Net income continuous Operations
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-1,528.78%-2.74M
-2,502.95%-2.76M
---2.89M
-129.71%-1.69M
---1.07M
---168.29K
---105.89K
Minority interest income
Net income attributable to the parent company
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-1,528.78%-2.74M
-2,502.95%-2.76M
-2.89M
-129.71%-1.69M
-1.07M
-168.29K
-105.89K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-1,528.78%-2.74M
-2,502.95%-2.76M
-2.89M
-129.71%-1.69M
-1.07M
-168.29K
-105.89K
Basic earnings per share
87.16%-0.01
61.69%-0.03
35.18%-0.0531
-1,528.74%-0.0779
-2,503.13%-0.0783
-0.082
-129.71%-0.0479
-0.0305
-0.0048
-0.003
Diluted earnings per share
87.16%-0.01
61.69%-0.03
35.18%-0.0531
-1,528.74%-0.0779
-2,503.13%-0.0783
-0.082
-129.71%-0.0479
-0.0305
-0.0048
-0.003
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022(FY)Jun 30, 2022(Q4)Jun 30, 2022(Q3)Mar 29, 2022(Q2)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -82.87%469.53K-62.97%1.02M-35.17%1.87M1,528.78%2.74M2,502.95%2.76M2.89M129.71%1.69M1.07M168.29K105.89K
Selling and administrative expenses 277.66%444.53K536.85%945.17K394.92%1.39M745.08%117.71K358.08%148.41K--280.26K7.16%296.25K--32.26K---18.25K--32.4K
-General and administrative expense 277.66%444.53K536.85%945.17K394.92%1.39M745.08%117.71K358.08%148.41K--280.26K7.16%296.25K--32.26K---18.25K--32.4K
Research and development costs -99.05%25K-97.11%75.46K-81.44%483.47K1,306.35%2.62M3,448.49%2.61M--2.61M203.81%1.39M--1.04M--186.54K--73.49K
Operating profit 82.87%-469.53K62.97%-1.02M35.17%-1.87M-1,528.78%-2.74M-2,502.95%-2.76M-2.89M-129.71%-1.69M-1.07M-168.29K-105.89K
Net non-operating interest income expense
Other net income (expense)
Income before tax 82.87%-469.53K62.97%-1.02M35.17%-1.87M-1,528.78%-2.74M-2,502.95%-2.76M-2.89M-129.71%-1.69M-1.07M-168.29K-105.89K
Income tax 0000000000
Net income 82.87%-469.53K62.97%-1.02M35.17%-1.87M-1,528.78%-2.74M-2,502.95%-2.76M-2.89M-129.71%-1.69M-1.07M-168.29K-105.89K
Net income continuous Operations 82.87%-469.53K62.97%-1.02M35.17%-1.87M-1,528.78%-2.74M-2,502.95%-2.76M---2.89M-129.71%-1.69M---1.07M---168.29K---105.89K
Minority interest income
Net income attributable to the parent company 82.87%-469.53K62.97%-1.02M35.17%-1.87M-1,528.78%-2.74M-2,502.95%-2.76M-2.89M-129.71%-1.69M-1.07M-168.29K-105.89K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 82.87%-469.53K62.97%-1.02M35.17%-1.87M-1,528.78%-2.74M-2,502.95%-2.76M-2.89M-129.71%-1.69M-1.07M-168.29K-105.89K
Basic earnings per share 87.16%-0.0161.69%-0.0335.18%-0.0531-1,528.74%-0.0779-2,503.13%-0.0783-0.082-129.71%-0.0479-0.0305-0.0048-0.003
Diluted earnings per share 87.16%-0.0161.69%-0.0335.18%-0.0531-1,528.74%-0.0779-2,503.13%-0.0783-0.082-129.71%-0.0479-0.0305-0.0048-0.003
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg